|
Steroid Diabetes in Patients With Kidney Disease
RECRUITINGSponsored by Zhejiang Provincial People's Hospital
Actively Recruiting
SponsorZhejiang Provincial People's Hospital
Started2024-01-10
Est. completion2026-12-31
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06161701
Summary
If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalbuminemia, high-dose hormone and other reasons, so they need to be closely followed up, identified and intervened in time.
Eligibility
Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Patients who need to use glucocorticoids due to the following diseases: nephrotic syndrome, Immunoglobulin A nephropathy, membranous nephropathy, Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), systemic lupus erythematosus; 2. Initial daily dose of glucocorticoids greater than or equal to 10mg of prednisolone; Exclusion Criteria: 1. Patients with diabetes; 2. Those who are unable to communicate through language; 3. Uremic patients; 4. Unable to perform blood glucose monitoring and follow-up as required; 5. Those who have used glucocorticoids within the past 3 months and have accumulated a dose of 10mg or more of prednisone; 6. Participated in other clinical studies。
Conditions2
DiabetesNephrotic Syndrome
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorZhejiang Provincial People's Hospital
Started2024-01-10
Est. completion2026-12-31
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06161701